Mixed options sentiment in ImmunityBio with shares down 0.99%

Mixed options sentiment in ImmunityBio (IBRX), with shares down 8c near $8.53. Options volume running well above average with 46k contracts traded and calls leading puts for a put/call ratio of 0.04, compared to a typical level near 0.32. Implied volatility (IV30) dropped 2.16 near 146.47, in the highest 10% of observations over the past year, suggesting an expected daily move of $0.79. Put-call skew flattened, suggesting a modestly bullish tone.Looking ahead: ImmunityBio (IBRX) will report earnings after the close on 2026-03-02.Option markets are pricing in a 50% probability of a move greater than 21.96% or $1.87.